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The ability of interleukin-1 (IL-l) to stimulate prostaglandin E, (PGE& production by human rheumatoid 
adherent synovial cells was found to be time-dependent and sensitive to protein synthesis inhibitors. Cells 
incubated with exogenous arachidonic acid (10 PM) showed no increase in PGE, production. However, with 
IL-l (2.5 U/ml) and exogenous arachidonic acid there was a marked increase, with levels reaching twice 
that for cells incubated with IL-l alone. Aspirin pre-treatment studies and the use of [acetyl-%]aspirin 
showed that IL-l increased PGE, production through the induction of cycle-oxygenase. 
Interleukin-1; Prostaglandin E,; Cycle-oxygenase; (Human rheumatoid synovial cell) 
1. INTRODUCTION 
Interleukin-1 is a polypeptide produced by 
macrophages which has potent amplifying effects 
on the inflammatory response [l]. One of its most 
striking properties is the induction of eicosanoid 
production, in particular PGEz [2], in several cell 
types, such as RASC. As PGEz itself is known to 
be important in the regulation of inflammatory 
processes [3] this effect might well be an important 
one in acute episodes of joint inflammation, par- 
ticularly in the light of recent findings which have 
indicated elevated levels of IL-l in rheumatoid 
joint synovial fluid [4]. As little is known about 
how IL-l achieves this effect, we have attempted to 
unravel part of the mechanism underlying this ac- 
tion, using cultured human RASC. The key con- 
trolling event in prostaglandin formation is usually 
interpreted as being activation of phospholipase 
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AZ. However, using cultured human RASC, we 
have shown that IL-2 causes PGE2 production 
through the induction of the enzyme cyclo- 
oxygenase, therefore phospholipase A2 activation 
does not appear to be the only limiting factor. 
2. EXPERIMENTAL 
2.1. Cells 
RASC were prepared as described [5] and grown 
to confluence in 24-well macrowell plates (Linbro) 
in DMEM (Gibco) supplemented with 10% heat- 
inactivated foetal calf serum (Gibco). 4th passage 
cells were used in all experiments, as low levels of 
spontaneously produced PGE2 were detectable. 
2.2. PGEz production 
IL-l (2.5 U/ml, Genzyme Ultrapure) was in- 
cubated with the cells (1.2 x lo5 per 500~1 well) 
and supernatants were removed at fixed times. The 
level of PGE2 in the supernatants was determined 
by radioimmunoassay as described by Jose et al. 
[6]. Cross-reactivities of the antiserum with other 
prostaglandins were as follows: PGEr, 26%; 
I=&, 1.1%; TxB2, <0.3%; 6-keto-PGFr,, 
0.03% and with arachidonic acid, 0.06%. Some of 
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the experiments were performed in the presence of 
exogenous arachidonic acid (10 ,uM, Sigma) which 
was added to the cells 1 h before determining 
PGE2 levels in the supernatant. The effect of 
cycloheximide (10 pg/ml, Sigma) and actinomycin 
D (10 pg/ml, Sigma) on the response was also 
evaluated. Neither showed signs of cytotoxicity as 
judged by trypan blue exclusion. 
2.3. The use of aspirin 
Aspirin was used to determine the effect of IL-l 
on cycle-oxygenase. Two series of experiments 
were carried out. Firstly, cells were pretreated for 
30 min with aspirin (lOOpM, Sigma) to allow the 
aspirin to inhibit all the cycle-oxygenase present. 
Cells were then washed twice with media, IL-1 
(2.5 U/ml) added and levels of PGE2 determined 
at fixed times (1 h after adding exogenous 
arachidonic acid (10 ,aM)) by radioimmunoassay. 
As aspirin causes an irreversible inhibition of 
cycle-oxygenase, prostaglandin production will 
only occur via the de novo synthesis of cyclo- 
oxygenase. 
In the second series of experimknts, 
[ace2yl-14C]aspirin (50 PM, spec. act. 25 &i/ 
mmol, Amersham) was used. IL-l (2.5 U/ml) was 
incubated with cells (1 x lo6 per incubation) for 
fixed time periods. [acefyl-‘4C]Aspirin was then 
added for 30 min at 37°C. Microsomes were 
prepared by centrifuging the cells at 100000 x g for 
45 min. Protein was then precipitated from the 
microsomal pellet and the amount of radioactivity 
determined. As the aspirin transfers its radioactive 
acetyl group specifically to cycle-oxygenase in this 
protocol [7], the radioactivity measured can be 
assumed to be due to the amount of cyclo- 
oxygenase present. 
3. RESULTS AND DISCUSSION 
Fig.1 shows that unstimulated cells (1.2 x lo5 
per 50081 well) produced low levels of PGEz 
(<3 ngeml-‘). IL-l (2.5 Uvml-‘), however, 
caused a time-dependent production of PGEz 
which increased from 3 -t 1 ng - ml-’ (n = 4) to 12 
+ 2 ng - ml-’ (n = 4) at 6-8 h incubation and to 54 
+ 3 ng *ml-’ (n = 4) after 24 h. PGEz levels began 
to rise only after 4 h, which is in agreement with 
Dayer et al. [B] who showed a similar lag phase us- 
ing mononuclear cell factor (MCF), a macrophage 
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Fig.1. Effect of IL-1 alone and in the presence ofarachidonic acid on PGE2 production by RASC. RASC (6 x 104 cmd2; 
2nd-4th subculture) prepared as described [5] were grown to confluence in 24-well macrowell plates (Linbro) in DMEM 
(Gibco) supplemented with 10% heat-inactivated foetal calf serum (Gibco) and incubated with DMEM alone (m) or IL-l 
(2.5 U *ml-‘, Genzyme Ultrapure; 0) or with arachidonic acid (10 pM, Sigma; O) or IL-1 with arachidonic acid added 
1 h before removal of supernatants (o), for fixed periods of time up to 24 h. Supernatants were then removed and the 
level of PGE2 was determined by radioimmunoassay as described by Jose et al. [6]. 
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product which has since been identified as IL-l. 
Fig.1 also shows that addition of arachidonic 
acid (10 ,uM) to unstimulated cells did not increase 
PGE2 production (3 f 1 ng - ml-‘, n = 3) but, 
when arachidonic acid was added to 
IL-l-stimulated cells, approximately twice as much 
PGE2 was produced (87 f 10 ng-ml-‘, n = 3) as 
compared with that produced by cells treated with 
IL-l alone. These findings indicated that IL-1 was 
increasing the metabolism of arachidonic acid to 
PGEI. and that release of arachidonic acid from 
membrane phospholipids by phospholipases was 
not the only controlling event. 
The delay of over 4 h in IL- 1 -induced PGE2 pro- 
duction was consistent with the view that protein 
synthesis might be involved in the response. Fig.2a 
confirms this and shows that the effect was in- 
hibited by the protein synthesis inhibitors, 
cycloheximide (10 pg - ml-‘) and actinomycin D 
(10 pg - ml-‘). Both synthesis inhibitors also 
blocked IL-l-induced PGEz formation by cells to 
which exogenous arachidonic acid had been added 
60- a 
PGEz 40. 
(“0 rni’ 1 
20. 
. CH AD ASP CH AD ASP 
1 HOUR 4 HOURS 8 HOURS 24 IiOWtS 
oJ , ‘ 
1 4 8 24 
TIME (HolRS) 
Fig.2. The effect of protein synthesis inhibitors and aspirin on IL-l-induced PGEs production by RASC. (a) RASC were 
incubated with IL-l (2.5 U-ml-‘) and either cycloheximide (CH, lO~g~ml_‘, Sigma), actinomycin D (AD, lO/rg.ml-‘, 
Sigma), aspirin (ASP, 100,~M, Sigma) or DMEM alone. PGEz levels were determined by radioimmunoassay in 
supernatants at the times indicated. Results are the mean f SE of 3 experiments, each comprising 3 replicates. None 
of the drugs showed signs of cytotoxicity as judged by trypan blue exclusion. (b) RASC were pretreated for 30 min with 
either DMEM (0) or aspirin (1OOrM) (0) to allow the aspirin to inhibit all cyclo-oxygenase present. Cells were then 
washed twice with DMEM, IL-1 (2.5 U.ml-‘) added and levels of PGEs determined at fixed times (1 h after adding 
exogenous arachidonic acid) by radioimmunoassay. Results are the mean f SE of 4 experiments, each comprising 3 
replicates. A t-test was used to assess the significance of the inhibitory effect of aspirin, * indicates P < 0.05. 
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(not shown). The finding agrees with that of Bern- 
heim and Dinarello [9] who showed the 
dependence on protein synthesis of IL-l-induced 
PGE2 release from human dermal fibroblasts. 
It seemed likely from the findings described 
above that an enzyme subsequent to phospholipase 
A2 in the metabolic pathway of arachidonic acid to 
PGE2, possibly cycle-oxygenase, was being in- 
duced by IL-l. Two experiments were designed 
with aspirin, as it is known that aspirin irreversibly 
inhibits cycle-oxygenase by acetylating the 
enzyme. 
Fig.2a shows the inhibitory effect of aspirin 
(100,uM) on the IL-l response, reducing PGE2 
production by the cells to 5 f 1 ng + ml-’ after 24 h 
incubation. However, when the cells were pre- 
incubated with aspirin for 30 min followed by 
washing to remove free aspirin which had not 
reacted with cycle-oxygenase, a different result 
was obtained (fig.2b). Initially, low amounts of 
PGEz were produced from exogenous arachidonic 
acid but, after 8 h incubation, PGE2 production 
was restored to 57 f 5 ng. ml-’ (n = 4) and to 
77 f 7 ngeml-’ (n = 4) after 24 h. These levels 
were similar to those from cells not pre-treated 
800 - 
600. 
with aspirin. This finding can only be explained by 
assuming that IL-l induced de novo synthesis of 
cycle-oxygenase. Residual cycle-oxygenase would 
be irreversibly acetylated by the aspirin and free 
aspirin in the culture medium would acetylate most 
of the newly-formed cycle-oxygenase. However, 
when the free aspirin was removed by washing, the 
newly synthesized cycle-oxygenase would be 
available to metabolise arachidonic acid. 
The second experiment using aspirin confirmed 
this finding. It has been shown that incubation 
with a low concentration of aspirin (50aM) for a 
short time (30 min) will result in specific and ir- 
reversible acetylation of cycle-oxygenase [7]. 
Using [acetyl-14C]aspirin, the labelled acetyl group 
is transferred to cycle-oxygenase with a 1: 1 
stoichiometry and thus radioactivity in microsomal 
protein precipitates gives a measure of the amount 
of cycle-oxygenase present. As can be seen in fig.3, 
radioactivity was increased in microsomal protein 
precipitates from cells incubated with IL-l. 
Furthermore, the increase occurred in a time- 
dependent manner similar 
production. 
The mechanism by which 
to that for PGEz 
IL-l stimulates cells 
r 
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Fig.3. Effect of IL-l (2.5 U.ml-‘) on the amount of cycle-oxygenase in RASC over 24 h. IL-1 (2.5 U.ml-‘; 0) or 
DMEM alone (0) were incubated with RASC (1 x lo6 per incubation) for fixed time periods. Cycle-oxygenase levels 
were then determined by incubating the cells with [acetyl-14C]aspirin (50 pM, spec. act. 25 @i.mmol-‘, Amersham) 
for 30 min at 37°C. Microsomes were then prepared and the radioactivity in precipitated protein determined. As the 
aspirin will transfer its radioactive acetyl group specifically to cycle-oxygenase in the protocol described [7], 
radioactivity measured (dpm) can be assumed to be due to the amount of cycle-oxygenase present. Results are mean 
f SE from triplicate determinations. 
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has not yet been fully elucidated. It appears not to 
act like some hormones in causing activation of 
adenylate cyclase or phosphatidylinositol turnover 
[lo]. Recent reports on how IL-l induces PGEz 
production by chondrocytes have indicated 
phospholipase A2 activation [ 111. This has also 
been shown in human synovial cells [ 121. Our 
results suggest that IL-l-induced cycle-oxygenase 
production in human RASC may be the more im- 
portant controlling event. This is similar to the 
mechanism proposed for other proteins which 
stimulate eicosanoid production, such as platelet- 
derived growth factor in mouse 3T3 fibroblasts 
t131. 
These findings not only illustrate the importance 
of cycle-oxygenase induction in controlling 
eicosanoid production, but point to a site of action 
of IL-l previously unsuspected, and perhaps sug- 
gest enzyme induction as a possible mechanism 
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